Aurinia Pharmaceuticals Inc (AUPH)
5.03
-0.06
(-1.08%)
USD |
NASDAQ |
Apr 24, 16:00
5.03
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Investing (TTM): -6.706M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.706M |
| September 30, 2023 | -3.467M |
| June 30, 2023 | -33.98M |
| March 31, 2023 | 17.24M |
| December 31, 2022 | -60.63M |
| September 30, 2022 | -63.10M |
| June 30, 2022 | -45.69M |
| March 31, 2022 | -89.64M |
| December 31, 2021 | -103.87M |
| September 30, 2021 | -79.24M |
| June 30, 2021 | -190.93M |
| March 31, 2021 | -213.31M |
| December 31, 2020 | -158.19M |
| September 30, 2020 | -177.36M |
| June 30, 2020 | -32.89M |
| March 31, 2020 | -8.233M |
| December 31, 2019 | 7.783M |
| September 30, 2019 | 23.88M |
| June 30, 2019 | 17.83M |
| March 31, 2019 | 23.85M |
| December 31, 2018 | -0.065M |
| September 30, 2018 | 70.82M |
| June 30, 2018 | -7.982M |
| March 31, 2018 | -24.98M |
| December 31, 2017 | -8.003M |
| Date | Value |
|---|---|
| September 30, 2017 | -91.93M |
| June 30, 2017 | -7.076M |
| March 31, 2017 | 3.987M |
| December 31, 2016 | 9.991M |
| September 30, 2016 | 6.955M |
| June 30, 2016 | 7.013M |
| March 31, 2016 | 2.944M |
| December 31, 2015 | -0.023M |
| September 30, 2015 | -0.043M |
| June 30, 2015 | -10.08M |
| March 31, 2015 | -10.09M |
| December 31, 2014 | -10.08M |
| September 30, 2014 | -10.08M |
| June 30, 2014 | -0.096M |
| March 31, 2014 | -0.096M |
| December 31, 2013 | -0.036M |
| September 30, 2013 | -0.0268M |
| June 30, 2013 | -0.0005M |
| March 31, 2013 | 0.8888M |
| December 31, 2012 | -0.0312M |
| September 30, 2012 | -0.1064M |
| June 30, 2012 | -0.0493M |
| March 31, 2012 | -0.9202M |
| December 31, 2011 | -1.151M |
| September 30, 2011 | -1.029M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-213.31M
Minimum
Mar 2021
23.88M
Maximum
Sep 2019
-63.18M
Average
-45.69M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Lexaria Bioscience Corp | -0.1991M |
| Acasti Pharma Inc | -1.452M |
| Edesa Biotech Inc | 0.00 |
| Xenon Pharmaceuticals Inc | -117.17M |
| ESSA Pharma Inc | 6.200M |